Literature DB >> 19630806

Regulation of megakaryocyte maturation and platelet formation.

D Bluteau1, L Lordier, A Di Stefano, Y Chang, H Raslova, N Debili, W Vainchenker.   

Abstract

Each day in every human, approximately 1 x 10(11) platelets are produced by the cytoplasmic fragmentation of megakaryocytes (MK), their marrow precursor cells. Platelets are the predominating factor in the process of hemostasis and thrombosis. Recent studies have shown that platelets also play a hitherto unsuspected role in several other processes such as inflammation, innate immunity, neoangiogenesis and tumor metastasis. The late phases of MK differentiation identified by polyploidization, maturation and organized fragmentation of the cytoplasm leading to the release of platelets in the blood stream represent a unique model of differentiation. The molecular and cellular mechanisms regulating platelet biogenesis are better understood and may explain several platelet disorders. This review focuses on MK polyploidization, and platelet formation, and discusses their alteration in some platelet disorders.

Entities:  

Mesh:

Year:  2009        PMID: 19630806     DOI: 10.1111/j.1538-7836.2009.03398.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  29 in total

Review 1.  Megakaryopoiesis and platelet production: insight into hematopoietic stem cell proliferation and differentiation.

Authors:  Tianyu Guo; Xuejun Wang; Yigong Qu; Yu Yin; Tao Jing; Qing Zhang
Journal:  Stem Cell Investig       Date:  2015-02-14

Review 2.  Megakaryopoiesis.

Authors:  Amy E Geddis
Journal:  Semin Hematol       Date:  2010-07       Impact factor: 3.851

Review 3.  Endoreplication.

Authors:  Norman Zielke; Bruce A Edgar; Melvin L DePamphilis
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-01-01       Impact factor: 10.005

4.  Uncoupling of the Hippo and Rho pathways allows megakaryocytes to escape the tetraploid checkpoint.

Authors:  Anita Roy; Larissa Lordier; Catherine Pioche-Durieu; Sylvie Souquere; Lydia Roy; Philippe Rameau; Valérie Lapierre; Eric Le Cam; Isabelle Plo; Najet Debili; Hana Raslova; William Vainchenker
Journal:  Haematologica       Date:  2016-08-11       Impact factor: 9.941

5.  Down-regulation of stathmin expression is required for megakaryocyte maturation and platelet production.

Authors:  Camelia Iancu-Rubin; David Gajzer; Joseph Tripodi; Vesna Najfeld; Ronald E Gordon; Ronald Hoffman; George F Atweh
Journal:  Blood       Date:  2011-03-01       Impact factor: 22.113

6.  microRNA-22 promotes megakaryocyte differentiation through repression of its target, GFI1.

Authors:  Cary N Weiss; Keisuke Ito
Journal:  Blood Adv       Date:  2019-01-08

Review 7.  Adipocytokines in atherothrombosis: focus on platelets and vascular smooth muscle cells.

Authors:  Giovanni Anfossi; Isabella Russo; Gabriella Doronzo; Alice Pomero; Mariella Trovati
Journal:  Mediators Inflamm       Date:  2010-06-28       Impact factor: 4.711

8.  Megakaryocyte-specific deletion of the protein-tyrosine phosphatases Shp1 and Shp2 causes abnormal megakaryocyte development, platelet production, and function.

Authors:  Alexandra Mazharian; Jun Mori; Ying-Jie Wang; Silke Heising; Benjamin G Neel; Steve P Watson; Yotis A Senis
Journal:  Blood       Date:  2013-03-18       Impact factor: 22.113

9.  Identification of regulators of polyploidization presents therapeutic targets for treatment of AMKL.

Authors:  Qiang Wen; Benjamin Goldenson; Serena J Silver; Monica Schenone; Vlado Dancik; Zan Huang; Ling-Zhi Wang; Timothy A Lewis; W Frank An; Xiaoyu Li; Mark-Anthony Bray; Clarisse Thiollier; Lauren Diebold; Laure Gilles; Martha S Vokes; Christopher B Moore; Meghan Bliss-Moreau; Lynn Verplank; Nicola J Tolliday; Rama Mishra; Sasidhar Vemula; Jianjian Shi; Lei Wei; Reuben Kapur; Cécile K Lopez; Bastien Gerby; Paola Ballerini; Francoise Pflumio; D Gary Gilliland; Liat Goldberg; Yehudit Birger; Shai Izraeli; Alan S Gamis; Franklin O Smith; William G Woods; Jeffrey Taub; Christina A Scherer; James E Bradner; Boon-Cher Goh; Thomas Mercher; Anne E Carpenter; Robert J Gould; Paul A Clemons; Steven A Carr; David E Root; Stuart L Schreiber; Andrew M Stern; John D Crispino
Journal:  Cell       Date:  2012-08-03       Impact factor: 41.582

Review 10.  Pathogenesis and management of inherited thrombocytopenias: rationale for the use of thrombopoietin-receptor agonists.

Authors:  Alessandro Pecci
Journal:  Int J Hematol       Date:  2013-05-01       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.